跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41,666 条关于
“Primary Immune Thrombocytopenia”
全部
41,666
临床试验
24,828
药物
505
机构
118
资讯
16,215
去年
InnoCare's Orelabrutinib Shows Promise in Treating Primary Immune Thrombocytopenia
去年
FDA Grants Orphan Drug Designation to Novartis' Ianalumab for Primary Immune Thrombocytopenia
3个月前
INNOCARE's BTK Inhibitor Orelabrutinib Receives New Drug Application Acceptance in China for Primary Immune Thrombocytopenia Treatment
23天前
FDA Grants Type B Pre-IND Meeting for RTX-NP (MabionCD20) in Immune Thrombocytopenia
去年
Thrombocytopenia Treatment Market Shows Promising Growth with Novel Therapies and Clinical Trials
去年
BioInvent Receives $1 Million Milestone as Takeda Advances Anti-CD83 Antibody Mezagitamab to Phase 3 for ITP
12个月前
Novartis Ianalumab Combination Shows 45% Improvement in ITP Disease Control in Phase III Trial
去年
Immune Thrombocytopenia Presents Diagnostic Challenges with Unpredictable Disease Course
去年
Global Thrombocytopenia Clinical Trials Market Sees Significant Growth in 2025
去年
FDA Approves Doptelet for Pediatric Immune Thrombocytopenia with New Sprinkle Formulation
第 1 页，共 1622 页
上一页
下一页
